|
Volumn 55, Issue 11, 2010, Pages 709-714
|
Are there guidelines for the responsible prescription of benzodiazepines?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANXIOLYTIC AGENT;
BENZODIAZEPINE DERIVATIVE;
PRESCRIPTION DRUG;
SEROTONIN UPTAKE INHIBITOR;
ADDICTION;
ANXIETY DISORDER;
ARTICLE;
CANADA;
CLINICAL PRACTICE;
DRUG UTILIZATION;
HUMAN;
MENTAL DISEASE;
PRACTICE GUIDELINE;
PSYCHOLOGICAL ASPECT;
RISK FACTOR;
STATISTICS;
TREATMENT OUTCOME;
UNITED STATES;
WITHDRAWAL SYNDROME;
ANTI-ANXIETY AGENTS;
ANXIETY DISORDERS;
BENZODIAZEPINES;
CANADA;
DRUG UTILIZATION;
GUIDELINES AS TOPIC;
HUMANS;
MENTAL DISORDERS;
PHYSICIAN'S PRACTICE PATTERNS;
PRESCRIPTION DRUGS;
RISK FACTORS;
SEROTONIN UPTAKE INHIBITORS;
SUBSTANCE WITHDRAWAL SYNDROME;
SUBSTANCE-RELATED DISORDERS;
TREATMENT OUTCOME;
UNITED STATES;
|
EID: 79952568432
PISSN: None
EISSN: 14970015
Source Type: Journal
DOI: 10.1177/070674371005501104 Document Type: Article |
Times cited : (32)
|
References (0)
|